home / stock / adil / adil news

ADIL News and Press, Adial Pharmaceuticals Inc From 09/27/23

Stock Information
Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com
Menu
ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...
ADIL - Purple Biotech, Allakos among healthcare movers

2023-09-27 09:59:57 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...
ADIL - Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relat...

ADIL - Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism

CHARLOTTESVILLE, Va., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals regains Nasdaq compliance

2023-08-23 09:42:06 ET More on Adial Pharmaceuticals Adial Pharmaceuticals reports Q2 results Adial Pharmaceuticals announces reverse stock split to regain compliance Adial Pharmaceuticals reports FY results Seeking Alpha’s Quant Rating on Adial Pharma...
ADIL - Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

CHARLOTTESVILLE, Va., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals reports Q2 results

2023-08-21 12:12:56 ET More on Adial Pharmaceuticals Adial Pharmaceuticals announces reverse stock split to regain compliance Adial Pharmaceuticals reports FY results Adial soars 63% after regulatory update on lead asset Adial gets cut at Maxim on need for ca...

ADIL - VMW, AAOI and FREV are among pre market gainers

2023-08-21 08:38:50 ET Timber Pharmaceuticals ( TMBR ) +121% to be Acquired by LEO Pharma. Tian Ruixiang  ( TIRX ) +52% . Electriq Power  ( ELIQ ) +31% . The Growth for Good Acquisition ( GFGD ) +24% for Good announce PIPE financing to s...
ADIL - Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Reported Positive Feedback from US and EU Regulatory Meetings Sale of Purnovate Significantly Reduces Cash Burn Rate Charlottesville, Va., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”)...

ADIL - Adial Pharmaceuticals announces reverse stock split to regain compliance

2023-08-04 09:00:19 ET Adial Pharmaceuticals Inc ( NASDAQ: ADIL ) Friday announced that it will effect a 1-for-25 reverse stock split of its common stock, par value $0.001 per share that will become effective on August 4, 2023 at 11:59 p.m. Eastern Time. Adial's common stock w...

ADIL - Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement and Reduce the Public Float

CHARLOTTESVILLE, Va., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...
Previous 10 Next 10